Open AccessMolecular Testing in Hematologic Malignancies
Author(s) -
Laura Zitella
Publication year - 2022
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2022.13.3.29
Subject(s) - medicine , hematologic neoplasms , hematologic disorders , fish <actinopterygii> , diagnostic test , session (web analytics) , intensive care medicine , computational biology , cancer , pediatrics , biology , computer science , fishery , world wide web
Molecular testing technologies have been increasingly integrated into clinical research and are essential tools in the care of patients with hematologic malignancies. During this session at JADPRO Live Virtual 2021, Laura J. Zitella, MS, RN, ACNP-BC, AOCN ® , reviewed key concepts for diagnostic testing with a focus on molecular testing (including cytogenetics, FISH, PCR, and next-generation sequencing) and discussed how to interpret the results for hematologic malignancies to inform prognosis as well as treatment.